Key statistics dashboard for CAMP4 Therapeutics Corporation (CAMP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Stock Data
| Price | $3.86 |
| Market Cap | $82M |
| Beta | 0.41 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.73 |
| Price / Book | -322.67 |
| P/S | 19.45 |
| P/FCF | -2.85 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 77.80% |
| EBIT Margin | -1766.51% |
| EBITDA Margin | -1735.48% |
| Operating Margin | -1242.50% |
| Net Margin | -2543.74% |
Financial Health
| Current Ratio | 4.70 |
| Quick Ratio | 4.70 |
| Cash Ratio | 4.55 |
| Debt / Equity | -3.42 |
| Debt / Assets | 2.54% |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.07 |
| Book Value per share | -0.01 |
| Cash per share | 1.50 |
| FCF per share | -0.50 |
| Tangible Book Value per share | -0.01 |
| Dividend per share | 0.00 |
Related companies: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explore sector: Healthcare · Biotechnology
More sections of CAMP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks